125 related articles for article (PubMed ID: 12682161)
61. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Katayama Y; Murakami-Kuroda H; Cui L; Hiramatsu K
Antimicrob Agents Chemother; 2009 Aug; 53(8):3190-6. PubMed ID: 19451283
[TBL] [Abstract][Full Text] [Related]
62. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
Mishra NN; Yang SJ; Sawa A; Rubio A; Nast CC; Yeaman MR; Bayer AS
Antimicrob Agents Chemother; 2009 Jun; 53(6):2312-8. PubMed ID: 19332678
[TBL] [Abstract][Full Text] [Related]
63. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.
Peleg AY; Monga D; Pillai S; Mylonakis E; Moellering RC; Eliopoulos GM
J Infect Dis; 2009 Feb; 199(4):532-6. PubMed ID: 19125671
[TBL] [Abstract][Full Text] [Related]
64. Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus.
Renzoni A; Kelley WL; Barras C; Monod A; Huggler E; François P; Schrenzel J; Studer R; Vaudaux P; Lew DP
Antimicrob Agents Chemother; 2009 Mar; 53(3):903-11. PubMed ID: 19104009
[TBL] [Abstract][Full Text] [Related]
65. Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary.
Banik JJ; Brady SF
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17273-7. PubMed ID: 18987322
[TBL] [Abstract][Full Text] [Related]
66. Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.
Chung M; Antignac A; Kim C; Tomasz A
Antimicrob Agents Chemother; 2008 Aug; 52(8):2709-17. PubMed ID: 18505853
[TBL] [Abstract][Full Text] [Related]
67. New antimicrobial agents as therapy for resistant gram-positive cocci.
Lentino JR; Narita M; Yu VL
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):3-15. PubMed ID: 17899228
[TBL] [Abstract][Full Text] [Related]
68. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
Fitzgibbon MM; Rossney AS; O'Connell B
J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
[TBL] [Abstract][Full Text] [Related]
69. Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus.
Pereira PM; Filipe SR; Tomasz A; Pinho MG
Antimicrob Agents Chemother; 2007 Oct; 51(10):3627-33. PubMed ID: 17646417
[TBL] [Abstract][Full Text] [Related]
70. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.
Mwangi MM; Wu SW; Zhou Y; Sieradzki K; de Lencastre H; Richardson P; Bruce D; Rubin E; Myers E; Siggia ED; Tomasz A
Proc Natl Acad Sci U S A; 2007 May; 104(22):9451-6. PubMed ID: 17517606
[TBL] [Abstract][Full Text] [Related]
71. Reversion of resistance in relapsing infection caused by a glycopeptide-intermediate methicillin-resistant Staphylococcus aureus isolate.
Huang TD; Almpanis C; Denis O; Nonhoff C; Delaere B; Glupczynski Y
Eur J Clin Microbiol Infect Dis; 2007 Jun; 26(6):419-22. PubMed ID: 17458569
[No Abstract] [Full Text] [Related]
72. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.
Wootton M; MacGowan AP; Walsh TR; Howe RA
J Clin Microbiol; 2007 Feb; 45(2):329-32. PubMed ID: 17108069
[TBL] [Abstract][Full Text] [Related]
73. Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.
Renzoni A; Barras C; François P; Charbonnier Y; Huggler E; Garzoni C; Kelley WL; Majcherczyk P; Schrenzel J; Lew DP; Vaudaux P
Antimicrob Agents Chemother; 2006 Sep; 50(9):3048-61. PubMed ID: 16940101
[TBL] [Abstract][Full Text] [Related]
74. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
[TBL] [Abstract][Full Text] [Related]
75. In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.
McCallum N; Karauzum H; Getzmann R; Bischoff M; Majcherczyk P; Berger-Bächi B; Landmann R
Antimicrob Agents Chemother; 2006 Jul; 50(7):2352-60. PubMed ID: 16801412
[TBL] [Abstract][Full Text] [Related]
76. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
[TBL] [Abstract][Full Text] [Related]
77. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin.
McAleese F; Wu SW; Sieradzki K; Dunman P; Murphy E; Projan S; Tomasz A
J Bacteriol; 2006 Feb; 188(3):1120-33. PubMed ID: 16428416
[TBL] [Abstract][Full Text] [Related]
78. Genetic background affects stability of mecA in Staphylococcus aureus.
Katayama Y; Robinson DA; Enright MC; Chambers HF
J Clin Microbiol; 2005 May; 43(5):2380-3. PubMed ID: 15872270
[TBL] [Abstract][Full Text] [Related]
79. First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil.
Palazzo IC; Araujo ML; Darini AL
J Clin Microbiol; 2005 Jan; 43(1):179-85. PubMed ID: 15634969
[TBL] [Abstract][Full Text] [Related]
80. Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center.
Bozdogan B; Ednie L; Credito K; Kosowska K; Appelbaum PC
Antimicrob Agents Chemother; 2004 Dec; 48(12):4762-5. PubMed ID: 15561854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
